Labshake search

701 - 709 of 709 citations for IL 1 beta Rat since 2019

• Antigen-presenting type-I conventional dendritic cells facilitate curative checkpoint blockade immunotherapy in pancreatic cancer

  Krishnan K. Mahadevan, et al., bioRxiv - Cancer Biology 2023

  Quote: ... Depletion of CD8+ T cells were performed simultaneously starting at the time of SP induction by administration of 200µg of anti-mouse CD8 (BioXcell, 53-6.7, BE0004-1) twice per week in 100 µL of PBS intraperitoneally for the entire course of the experiments ...
• Enhancing anti-EGFRvIII CAR T cell therapy against glioblastoma with a paracrine SIRPγ-derived CD47 blocker

  Tomás A. Martins, et al., bioRxiv - Cancer Biology 2023

  Quote: ... Cells were then treated for 30 min at 4°C with 50 µL per well of 10 µg/mL of InVivoMAb anti-human CD47 (clone B6.H12; #BE0019-1, Bio X Cell, USA) or InVivoMAb mouse IgG1 isotype control (clone MOPC-21 ...
• The immunocytokine L19-TNF eradicates Sarcomas in combination with Chemotherapy agents or with immune check-point inhibitors

  Riccardo Corbellari, et al., bioRxiv - Cancer Biology 2020

  Quote: ... trabectedin (Yondelis®, PharmaMar AG), melphalan (Alkeran®, Aspen Pharma Schweiz GmbH) and the anti-PD-1 antibody (clone 29F.1A12, BioXCell, Catalog # BE0273) were purchased.
• Upregulated PD-1 Signaling is an Important Antagonist to Glomerular Health in Aged Kidneys

  Jeffrey W. Pippin, et al., bioRxiv - Cell Biology 2021

  Quote: ... anti-PD-1 antibody-injected group (n=12) that received weekly IP injections of InVivoMAb anti-mouse PD-1 antibody (RMP1-14, Bio X Cell, Lebanon, NH) at 12 mg/kg for 8 weeks ...
• Lymphatic-Preserving Treatment Sequencing with Immune Checkpoint Inhibition Unleashes cDC1-Dependent Antitumor Immunity in HNSCC

  Robert Saddawi-Konefka, et al., bioRxiv - Cancer Biology 2022

  Quote: ... anti-CTLA4 (clone 9H10, BP0131), anti-Ly6G (clone 1A8, BE0075-1) and IFNAR depleting antibodies (Clone MAR1-5A3, BE0241) were purchased from Bio X Cell (West Lebanon, NH). Fluorochrome-conjugated antibodies were purchased from BD Biosciences (San Jose ...
• Metastatic Single Tumor Cells Evade NK Cell-mediated Killing by Thrombin-mediated Loss of the Activating Ligand CD155/PVR/Necl-5

  Hiroshi Ichise, et al., bioRxiv - Immunology 2021

  Quote: ... The following antibodies were used for in vivo blocking experiments: anti-LFA-1α (M17/4) and anti-Mac-1 (M1/70) (both from Bio X Cell, West Lebanon, NH). The following antibodies or reagents were used for in vivo cell depletion ...
• NPRL2 gene therapy induces effective antitumor immunity in KRAS/STK11 mutant anti-PD1 resistant metastatic non-small cell lung cancer (NSCLC) in a humanized mouse model

  ISMAIL M MERAZ, et al., bioRxiv - Cancer Biology 2024

  Quote: ... Anti-PD-1 (catalog no. BE0146 [clone RMP1-14]) and InVivoPlus isotype Abs (catalog no. BE0089 [clone 2A3]) were purchased from Bio X Cell (West Lebanon, NH). Treatment schedules and dosages are shown schematically in figures ...
• Reactive myelopoiesis and FX-expressing monocyte-derived macrophages triggered by chemotherapy promote cancer lung metastasis

  Caijun Wu, et al., bioRxiv - Immunology 2022

  Quote: ... CD4 and CD8 T cells was performed by IP injection of anti-Ly6G mAb (300 μg, twice a week, Bio X Cell, Cat. No. BE0075-1), anti-CD4 (clone GK1.5 ...
• Human Rhinoviruses: a novel class of oncolytic virus

  William J Burnett, et al., bioRxiv - Immunology 2023

  Quote: ... The αPD-1 antibody (clone RMP1-14; BE0146) and the isotype control antibody (clone 2A3; BE0089) were obtained from Bio X Cell (West Lebanon, NH, USA). αPD-1 and isotype control antibodies were delivered systemically by IP injection on days 1 ...